Cohen Capital Management Inc. increased its stake in Aetna Inc. (NYSE:AET) by 0.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,050 shares of the company’s stock after buying an additional 350 shares during the period. Aetna makes up approximately 1.6% of Cohen Capital Management Inc.’s investment portfolio, making the stock its 26th largest position. Cohen Capital Management Inc.’s holdings in Aetna were worth $5,547,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Atria Investments LLC bought a new position in shares of Aetna during the second quarter valued at approximately $222,000. FirstMerit Bank N A Trustee bought a new position in shares of Aetna during the second quarter valued at approximately $200,000. Gulf International Bank UK Ltd raised its position in shares of Aetna by 0.7% in the second quarter. Gulf International Bank UK Ltd now owns 104,685 shares of the company’s stock valued at $12,785,000 after buying an additional 700 shares in the last quarter. TT International raised its position in shares of Aetna by 3.7% in the second quarter. TT International now owns 28,465 shares of the company’s stock valued at $3,476,000 after buying an additional 1,010 shares in the last quarter. Finally, Chevy Chase Trust Holdings Inc. increased its stake in shares of Aetna by 1.7% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 305,031 shares of the company’s stock valued at $37,254,000 after buying an additional 5,026 shares during the last quarter. Hedge funds and other institutional investors own 88.28% of the company’s stock.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Shares of Aetna Inc. (NYSE:AET) traded down 0.91% during mid-day trading on Monday, reaching $128.39. 1,862,848 shares of the company were exchanged. Aetna Inc. has a 12 month low of $92.42 and a 12 month high of $131.08. The firm has a market capitalization of $45.05 billion, a price-to-earnings ratio of 18.52 and a beta of 0.54. The company’s 50-day moving average is $114.92 and its 200 day moving average is $116.41.

Aetna (NYSE:AET) last announced its quarterly earnings results on Thursday, October 27th. The company reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $2.02 by $0.05. The firm had revenue of $15.78 billion for the quarter, compared to analysts’ expectations of $15.71 billion. Aetna had a net margin of 3.91% and a return on equity of 16.25%. Aetna’s revenue was up 5.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.90 earnings per share. Analysts predict that Aetna Inc. will post $8.02 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Aetna Inc. (AET) Stake Raised by Cohen Capital Management Inc.” was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The correct version of this report can be accessed at https://www.thecerbatgem.com/2016/11/28/aetna-inc-aet-stake-raised-by-cohen-capital-management-inc.html.

Several brokerages recently weighed in on AET. Zacks Investment Research raised shares of Aetna from a “sell” rating to a “hold” rating in a research note on Tuesday, November 22nd. FBR & Co reaffirmed a “hold” rating on shares of Aetna in a research note on Wednesday, August 17th. Credit Suisse Group AG reaffirmed a “hold” rating and set a $120.00 target price on shares of Aetna in a research note on Wednesday, August 17th. Jefferies Group reaffirmed a “hold” rating on shares of Aetna in a research note on Tuesday, August 23rd. Finally, Sanford C. Bernstein downgraded shares of Aetna from an “outperform” rating to a “market perform” rating and set a $132.00 target price on the stock. in a research note on Monday, November 14th. Seven investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $132.14.

In other news, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total transaction of $827,221.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.90% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).

5 Day Chart for NYSE:AET

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.